TITLE

Successful treatment of methicillin-resistant Staphylococcus aureus (MRSA) mediastinitis in a heart transplant recipient

AUTHOR(S)
Pasic, Miralem; Schaffarczyk, Raymond; Hetzer, Roland
PUB. DATE
June 2004
SOURCE
European Journal of Cardio-Thoracic Surgery;Jun2004, Vol. 25 Issue 6, p1127
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
We report on the first case of successfully treated severe methicillin-resistant Staphylococcus aureus (MRSA) mediastinitis after heart transplantation. The therapy consisted of wrapping of the heart with the transposed greater omentum, 4-week local irrigation and prolonged aggressive antibiotic therapy with vancomycin and linezolid.
ACCESSION #
13115606

 

Related Articles

  • Girl is healthy three and a half years after her donor heart. Henderson, Daniel M. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;7/18/2009, Vol. 339 Issue 7713, p126 

    The article reports on the case of 16-year-old girl Hannah Clark who is fit and well three and a half years after the removal of a donor heart that had been transplanted alongside her own. At the age of 8 months, she was presented with signs of severe heart failure, secondary to idiopathic...

  • Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant. Gandhi, Manish J.; Pierce, Richard A.; Zhang, Lini; Moon, Marc R.; Despotis, George J.; Moazami, Nader // Journal of Cardiothoracic Surgery;2007, Vol. 2, p32 

    Background: Ventricular assist devices(VAD) implantation/removal is a complex surgical procedure with perioperative bleeding complications occurring in nearly half of the cases. Recombinant activated factor VII (rFVIIa) has been used off-label to control severe hemorrhage in surgery and trauma....

  • Indication for Pediatric Heart Transplantation - Romanian Peculiarities. Anca, Sglimbea; Roxana, Toma; Suciu, H.; Deac, R. // Acta Medica Marisiensis;2012, Vol. 58 Issue 6, p451 

    Background: Heart transplantation is nowadays a well established and succesfull therapy in both pediatric and adult heart failure. There are several guidelines for adult transplantation, while pediatric transplantation benefits of the indications established in 2007 by the American Heart...

  • Exercise after heart transplantation. Marconi, Claudio; Marzorati, Mauro // European Journal of Applied Physiology;Oct2003, Vol. 90 Issue 3/4, p250 

    Exercise intolerance in heart transplant recipients (HTR) has a multifactorial origin, involving complex interactions among cardiac, neurohormonal, vascular, skeletal muscle and pulmonary abnormalities. However, the role of these abnormalities may differ as a function of time after...

  • Cumulative risk adjusted monitoring of 30-day mortality after cardiothoracic transplantation: UK experience. Rogers, Chris A.; Ganesh, J. Saravana; Banner, Nicholas R.; Bonser On behalf of the steering Group, Robert S. // European Journal of Cardio-Thoracic Surgery;Jun2005, Vol. 27 Issue 6, p1022 

    Abstract: Objective: Guidelines are needed for real-time quality monitoring in heart and lung transplantation. The cumulative sum (CUSUM) methodology with boundary limits derived from the sequential probability ratio test (SPRT) provide a means of monitoring performance without the need for...

  • Psychological Adjustment After Cardiac Transplantation.  // JAMA: Journal of the American Medical Association;3/10/89, Vol. 261 Issue 10, p1438 

    Discusses the abstract of a research study concerning psychological adjustment after cardiac transplantation. Emotional impact of cardiac transplantation on recipients and their families; Recipients' anxiety, depression, body image and subjective quality of life; Satisfaction of the patients...

  • Biatrial Masses in a Heart Transplant Patient. Ali, Asghar; Robati, Roshanak; Lewis, Neil P.; Elshowaia, Salwa; Jovin, Ion S. // Texas Heart Institute Journal;2012, Vol. 39 Issue 6, p908 

    The article focuses on the case of a 55-year-old man who developed intracardiac thrombus 20 years after orthotopic heart transplantation. Some of the symptoms experienced by the patient include hypotension, altered mental status and atrial fibrillation. It outlines some of the methods for...

  • Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation—a preliminary study. Martin, Juergen; Siegenthaler, Michael P.; Friesewinkel, Ortwin; Fader, Tina; van de Loo, Andreas; Trummer, Georg; Berchtold-Herz, Michael; Beyersdorf, Friedhelm // European Journal of Cardio-Thoracic Surgery;Jun2004, Vol. 25 Issue 6, p971 

    Objectives: Elevated pulmonary vascular resistance (PVR) unresponsive to pharmacological intervention is a major limitation in heart transplantation (HTX). The post-operative course of these patients is associated with an increased risk of life-threatening right heart failure. We evaluated the...

  • Morphometric changes of the right ventricle in the first two weeks after clinical heart transplantation: analysis of myocardial biopsies from patients with complicated versus uncomplicated course. Koch, Achim; Geil-Bierschenk, Cornelius; Rieker, Ralf; Dengler, Thomas J.; Sack, Falk-Udo; Schirmacher, Peter; Hagl, Siegfried; Schnabel, Philipp A. // European Journal of Cardio-Thoracic Surgery;Aug2006, Vol. 30 Issue 2, p370 

    Abstract: Objective: The early phase following heart transplantation (HTx) is characterized by the development of right ventricular myocardial fibrosis (MF) and cardiomyocyte hypertrophy (CH). The question is if there are differences in development of MF and CH between patients with complicated...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics